SVG Sprites

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles

TAKE ACTION

Whether it’s a sore throat, diabetes or asthma or cancer, we all deserve affordable prescription medicines to feel better when we’re sick. It’s time to stop drug corporations from putting their profits ahead of our families and our health. Together, we can end big Pharma’s price-gouging, and rewrite the rules so everyone can afford the medicines they need to care for themselves and their families.

Our Principles

No matter where people live, what they look like or what’s in their wallets, at some point everyone is going to get sick and need prescription medicines. Whether it’s a sore throat, high blood pressure or cancer, everyone needs affordable medicine to lead healthy lives.

But today, drug corporations and their powerful Pharma lobbyists are standing in the way of our health and economic security. By jacking up prices to boost profits, they are forcing people to make stark choices – like choosing between medicine and other necessities, or going without treatment, or going into debt or watching loved ones suffer without the drugs they need to get better.

It doesn’t have to be this way. Together, we can change the system to make sure everyone gets access to medicines they can afford. We are a coalition that has come together to fight for transformative, bold reforms through legislative, legal and executive actions at the state and federal level based on these four principles:

GOVERNMENT RESPONSIBILITY

It is our government’s responsibility to guarantee that everyone in the United States, no matter where they live, what they look like or how much money they have, can afford the medicines they need to stay healthy and take care of their families. We oppose policies that put medicine out of reach for Americans or that deny or delay access to medicine for people in other countries.

AFFORDABLE ACCESS

Drug corporations and their lobbyists have rigged the rules of the pharmaceutical industry in order to drive up profits, putting medicines out of reach for millions of people. Their price gouging makes health and economic disparities even worse by putting the greatest pressure on the people who can least afford to bear the brunt of high prices. We must topple the barriers that systematically deny people access to medicines so that no one is left behind.

MAKING THE SYSTEM FAIR

We must curb drug corporations’ power to extract profits at the expense of people’s health by harnessing the government’s power to improve patients’ lives. This requires a range of concrete steps that re-write the rules to rein in drug corporations’ monopoly power to price gouge; that requires the drug industry to negotiate fair prices with government; and that holds corporations accountable for practices that directly and indirectly keep prices unjustifiably high.

PUTTING PUBLIC GOOD AHEAD OF CORPORATE PROFIT

We as taxpayers help foot the bill for a substantial amount of drug research, development and innovation, for drug purchasing through Medicare, Medicaid, and the Veterans Administration and for marketing, legal and patent protections for drug corporations. We must ensure government funding and incentives prioritize medical breakthroughs that most serve the public good rather than those that primarily extend monopolies and increase corporate profits. Everyone wants proven treatments and life-saving innovations, but prescription drugs are useless to people who can’t afford them. We must change the system to make sure everyone can benefit from our shared public investment in new drug research and development by ensuring that medicines are affordable and accessible to everyone.

Press

LDPN In the News 03.01.2024

Federal Judge Dismisses Another Pharma Lawsuit

U.S. District Judge Colm Connolly’s decision today to dismiss AstraZeneca’s frivolous lawsuit is another big will for the Biden Administration and the millions of Medicare enrollees who will get lower drug costs under the new Medicare reforms passed in 2022. This is the third favorable ruling against legal challenges to Medicare negotiations and we remain confident that we’ll see a similar ruling in the upcoming hearing on March 7th in the New Jersey hearing during which Bristol Myers Squibb, Novo Nordisk, Novartis and Johnson & Johnson will present their oral arguments against Medicare negotiations.

LDPN In the News 02.09.2024

Pitchfork Economics: Medicare Drug Price Negotiations with Margarida Jorge

The pharmaceutical industry is one of the most opaque industries in America, and they take advantage of this lack of transparency by setting ever-higher prices for lifesaving prescription drugs like insulin. But provisions in the Inflation Reduction Act are curtailing the exorbitant price-gouging strategies that the pharmaceutical industry uses to pump up their profit margins at the expense of seniors and people with disabilities who use Medicare.

Blog 02.05.2024

New Medicare reform law makes life-changing impact on patients

After decades of fighting PhRMA’s lobbyists, patients, advocates and lawmakers scored a huge victory for lower drug prices with passage of the 2022 Inflation Reduction Act, a new law that includes Medicare reforms that take on drug corporations’ price-gouging and make medicines more affordable for millions.

Coalition Members